DIMS Institute of Medical Science, Inc.

Developers of Medium-term Carcinogenesis Bioassays in the world. / Contract safety research facility.

Mission

HOME ≫ GLP inspection ≫

GLP inspection

Japanese PMDA GLP (Nonclinical Safety Studies of Drugs)

医薬品GLP適合確認書_

The number of times	Evaluation grade	Date of notice
8^th	Grade A	September 11^th, 2014
9^th	Accommodation	August 18^th, 2017
10^th	Accommodation	December 25^th, 2020

Japanese PMDA GLP (Nonclinical Safety Studies of Regenerative Medical Products)

再生医療等製品GLP適合確認書_

The number of times	Evaluation grade	Date of notice
1^st	Accommodation	December 25^th, 2020

Japanese Chemical Substances Control Law GLP

化審法2021_

The number of times	Evaluation grade	Date of notice
9^th	Accommodation	October 24^th, 2014
10^th	Accommodation	September 4^th, 2017
11^th	Accommodation	February 16^th, 2021

Japanese Ministry of Agriculture, Forestry and Fisheries GLP

農水2021_

The number of times	Evaluation grade	Date of notice
10^th	Accommodation	July 5^th, 2016
11^th	Accommodation	May 22^th, 2019
12^th	Accommodation	March 29^th, 2021

Medium-term Carcinogenesis Bioassay/Safety Assessment for Developing Products

DIMS Institute of Medical Science, Inc.

64 Goura, Nishiazai,
Azai-cho, Ichinomiya,
Aichi 491-0113, Japan

Tel: +81-586-51-1201
Fax: +81-586-51-5634

Company Profile

Side Menu

Mobile site

DIMS Institute of Medical Science, Inc.スマホサイトQRコード

Access to the mobile site of DIMS. from this QR code.